Avalo Therapeutics, Inc. ($AVTX)
Filing Information
| Accession Number | 0001918845-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 18, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
76,476
Total Value
$706,457.26
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Mar 16, 2026 | Exercise/Conversion | 19,500 | $12.65 | $246,675.00 | 23,122 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 16, 2026 | Exercise/Conversion | 5,992 | $8.04 | $48,175.68 | 29,114 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 16, 2026 | Sale | 25,492 | $16.15 | $411,606.58 | 3,622 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Mar 16, 2026 | Exercise/Conversion | 19,500 | $0.00 | $0.00 | 214,500 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Mar 16, 2026 | Exercise/Conversion | 5,992 | $0.00 | $0.00 | 149,008 | Direct | โ | View Details |